Startup Creator Launched to Fill Europe’s Microbiome Translational Gap
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the…
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the…
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
French company MaaT Pharma has raised €18M in Series B financing that will support phase…
Lyon is one of the hotspots for biotech in Europe. Here are 10 of the…
The death of a US patient from complications after a fecal transplant last week could…
European microbiome biotechs have launched a collaboration to streamline the EU’s regulatory pathways for microbiome-based…
Scientists are uncovering many ways that the microorganisms that share our body can influence our…
A clinical trial run by MaaT Pharma has shown that restoring the microbiome of patients…
MaaT Pharma, based in Lyon, has received authorization to launch a Phase II trial for…
Yesterday, a panel of experts at BioTrinity discussed the huge possibilities offered by the young…
We gathered the best of the best companies in Europe working on therapies from the microbiome…